Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00736996 · ClinicalTrials.gov registry record · Phase 2
Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI)
A Phase 2 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 2
- Development phase
- 78
- Enrollment target
NCT00736996 is a Phase 2 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 78 participants.
The verdict
NCT00736996, a Phase 2 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 78 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate novel treatments to delay progression to dementia in patients with mild cognitive impairment (MCI) and metabolic syndrome (MS). The hypothesis is that treatment with pioglitazone or endurance exercise training will improve, stabilize, or attenuate decline in cognitive function compared to controls. This study will also discover potential mechanisms for the improvements and determine the baseline prevalence of amnestic versus non-amnestic MCI.
Interventions
- DRUG Placebo
- DRUG Pioglitazone
- BEHAVIORAL Endurance Exercise Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2008-11 |
| Est. Completion | 2013-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00736996
The ClinicalTrials.gov registry entry for NCT00736996 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00736996 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00736996 about?
NCT00736996 is a clinical study titled "Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI)". The purpose of this study is to investigate novel treatments to delay progression to dementia in patients with mild cognitive impairment (MCI) and metabolic syndrome (MS). The hypothesis is that treatment with pioglitazone or endurance exercise training will improve, stabilize, or attenuate decline ...
What is the current status of trial NCT00736996?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 78 participants. The study started on 2008-11. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00736996?
The interventions under investigation include: Placebo (DRUG), Pioglitazone (DRUG), Endurance Exercise Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT00736996?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.